Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Older woman having problems with vision | Image credit: Home-stock - stock.adobe.com
5 Things to Know During AMD Awareness Month

February 7th 2025

Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.

AMD Test | Image credit: Andrey Popov - stock.adobe.com
Brolucizumab Effective in Patients With Wet AMD, Regardless of Past Treatment

February 4th 2025

FDA approved. | Image Credit: Pawel - stock.adobe.com
FDA Approves Ranibizumab Implant in Treatment of DME

February 4th 2025

Semaglutide | Image credit: Starmarpro - stock.adobe.com
Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications

January 30th 2025

Macular degeneration | Image credit: RFBSIP - stock.adobe.com
Resveratrol Oral Supplement Associated With Lower Rates of Intravitreal Aflibercept Injections

January 30th 2025

Continuing Medical Education
View All
February 7th 2025

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

2.0 Credits / Ophthalmology/Optometry
February 7th 2025

Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies

1.5 Credits / Ophthalmology, Optometry
February 7th 2025

Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes

1.5 Credits / Ophthalmology/Optometry
February 7th 2025

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology
February 7th 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

More News

Site Logo
May 1st 2017

Women Get Attention in Healthy Vision Month

Mary Caffrey
People with diabetes are particularly in need of regular eye exams to get for signs of diabetic retinopathy, which can lead to blindness.
Site Logo
August 31st 2016

Telemedicine May Help Promote Eye Exam Access for People With Diabetes

Jackie Syrop
A nationwide telemedicine diabetic screening program could help prevent diabetic retinopathy, the top cause of new-onset blindness in the United States.
Communicating With Providers About Diabetes-Related Eye Diseases
March 23rd 2016

Communicating With Providers About Diabetes-Related Eye Diseases

Diabetic Macular Edema: The Value of Slowing Progression
March 23rd 2016

Diabetic Macular Edema: The Value of Slowing Progression

Diabetes-Related Eye Diseases: Making Coverage Decisions
March 23rd 2016

Diabetes-Related Eye Diseases: Making Coverage Decisions

Diabetic Macular Edema: Addressing Barriers to Screening
March 23rd 2016

Diabetic Macular Edema: Addressing Barriers to Screening

Understanding the Clinical and Economic Burden of Diabetes-Related Eye Diseases
March 23rd 2016

Understanding the Clinical and Economic Burden of Diabetes-Related Eye Diseases

The Future Outlook on Diabetes Care and the Prevention and Treatment of Eye Diseases
March 23rd 2016

The Future Outlook on Diabetes Care and the Prevention and Treatment of Eye Diseases

The Impact of Healthcare Reform on Diabetes Care
March 23rd 2016

The Impact of Healthcare Reform on Diabetes Care

Understanding Treatment Risks, Benefits, and Value in Diabetic Macular Edema
March 23rd 2016

Understanding Treatment Risks, Benefits, and Value in Diabetic Macular Edema

Treatment of Diabetic Macular Edema: Physician Choice Versus Cost Management
March 23rd 2016

Treatment of Diabetic Macular Edema: Physician Choice Versus Cost Management

The Role of Anti-VEGF Therapy in Diabetic Macular Edema
March 23rd 2016

The Role of Anti-VEGF Therapy in Diabetic Macular Edema

Early Intervention in Diabetic Retinopathy: Health Plan Incentives and Patient Engagement
March 23rd 2016

Early Intervention in Diabetic Retinopathy: Health Plan Incentives and Patient Engagement

The Diabetes Healthcare Team: When Is a Specialist Needed?
March 23rd 2016

The Diabetes Healthcare Team: When Is a Specialist Needed?

The Utility of Frequent Glucose Monitoring in Patients With Diabetes
March 23rd 2016

The Utility of Frequent Glucose Monitoring in Patients With Diabetes

Reducing the Risk for Diabetic Retinopathy and Diabetic Macular Edema
March 23rd 2016

Reducing the Risk for Diabetic Retinopathy and Diabetic Macular Edema

The Risk for Developing Diabetes-Related Eye Diseases: What Do Patients Know?
March 23rd 2016

The Risk for Developing Diabetes-Related Eye Diseases: What Do Patients Know?

Overcoming Barriers to Eye Examinations Among Patients with Diabetes
March 23rd 2016

Overcoming Barriers to Eye Examinations Among Patients with Diabetes

Screening for Eye Problems in Patients With Diabetes
March 23rd 2016

Screening for Eye Problems in Patients With Diabetes

Diabetic Macular Edema and Other Diabetes-Related Eye Diseases: The Cost Burden
March 23rd 2016

Diabetic Macular Edema and Other Diabetes-Related Eye Diseases: The Cost Burden

Site Logo
February 23rd 2016

Smart Cards Wouldn't Stop Most Healthcare Fraud, GAO Finds

Mary Caffrey
While smart cards would stop about 20% of fraudulent act, it wouldn't catch acts in which providers or beneficiaries are complicit, such as billing for unnecessary services.
Site Logo
December 2nd 2014

Integrated Health Benefits Plans Gaining Attention

Laura Joszt, MA
Employers and employees are seeing eye-to-eye when it comes to integrated health benefits. Not only do employees see how an integrated plan can improve quality of care and health, but employers see how it makes good business sense.
Site Logo
December 10th 2013

Drug Cost Not an Indication of Effectiveness

Katie Sullivan
In the battle to control costs and out-of-pocket expenses for consumers, it would seem logical that doctors would choose the lower-cost drug. However, a report found that when given the choice, doctors chose the more expensive eye medicine over a lower cost option, even when both prescriptions provided the same effective treatment.
<1
...
131415161718>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo